Oddway International Announces Addition of Danavir to Its Product Inventory

Danavir 600 mg Tablets Composition of Darunavir, HIV Drug by Hetero Labs Ltd

Press Release (ePRNews.com) - India - Aug 17, 2017 - Oddway International, one of the largest exporters of Wholesale Speciality Medicines, represents yet another effective medicine; Danavir manufactured by Hetero Labs Ltd which contains Darunavir in the form of tablets, in their extensive distribution of product portfolio.

Danavir 600 mg drug is used with other HIV medications to help control HIV infection. It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. Darunavir belongs to a class of drugs known as protease inhibitors.

Oddway International has announced product catalogs of over 30 categories and offers hundreds of high quality products at reasonable prices in each category. They pride themselves on the “quality control” and “quality assurance” they provide to national and international customers to improve health and well-being with high quality pharmaceutical products.

About Oddway International

In business for over 7 years, Oddway International has established its name not only in India but also in other countries through their exceptional product range. The company is among the leading generics and branded generics companies in India have a strong export base clientele and market capitalization. The company mainly caters to international markets and is working in about 25 counties. Its prime focus remains extension of its portfolio by addition of new products and entering new markets around the world and exploring new business opportunities. At Oddway, it is believed that customer satisfaction, in terms of quality, delivery and after sales follow-up, is first and foremost responsibility.

Source : Pharmaceutical Wholesaler Supplier In India

You may also like this  

CATEGORIES : Alternative Medicine
DISCLAIMER : If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/services/business mentioned and hereby disclaims any content contained in this press release.

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login